Preclinical studies have shown that NGF gene delivery can prevent cholinergic degeneration and enhance cognitive performance in rodent and primate models [9,10], while BDNF supplementation has been shown to restore synaptic integrity and memory function independently of amyloid clearance [11-13]. The gene discussed is BDNF; the disease is amyloidosis.